|
|
Aging-Related Biomarkers of Neurocognitive Function in Long-term Hodgkin Lymphoma Survivors |
| 1 K99 CA256356-01 |
|
NCI |
2021 |
|
|
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects |
| 1 R01 CA248103-01A1 |
|
NCI |
2021 |
|
|
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy. |
| 1 R01 CA249988-01A1 |
|
NCI |
2021 |
|
|
Development of A HTLV-1 Vaccine |
| 1 R01 CA252049-01A1 |
BARBER, GLEN N |
NCI |
2021 |
|
|
CCL2 and CCR2 as metastatic drivers and therapeutic targets in medulloblastoma |
| 1 R01 CA255369-01 |
|
NCI |
2021 |
|
|
Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy |
| 1 R01 CA259188-01 |
|
NCI |
2021 |
|
|
Image-guided combination therapies for radiotherapy-induced neurocognitive impairment in pediatric brain tumor survivors |
| 1 R01 CA262887-01 |
|
NCI |
2021 |
|
|
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system |
| 1 R01 CA263806-01 |
BOTA, DANIELA ANNENELIE |
NCI |
2021 |
|
|
Candidate mechanisms for chemotherapy-induced neurocognitive deficits in pediatric solid non-CNS tumor patients |
| 1 R21 CA262491-01 |
BAKER, TRAVIS E |
NCI |
2021 |
|
|
Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors |
| 1 R21 CA262978-01 |
|
NCI |
2021 |
